| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/16/2004 | CN1505510A Medicine combinations using pyridoindolone derivatives and anticancer agent as base |
| 06/16/2004 | CN1505509A Method for treating allergies using substituted pyrazoles |
| 06/16/2004 | CN1505505A Composition for administration to mucosa and containing coenzyme Q as active ingredient |
| 06/16/2004 | CN1504462A Pyrimidinyl derivatives as interleukin inhibitors |
| 06/16/2004 | CN1504233A Lucid ganoderma oral liquid |
| 06/16/2004 | CN1504200A Red-legged disease, curlworm disease ecotype, immunity and prevention and cure technique of eelworm |
| 06/16/2004 | CN1504199A Luminescent bio-element and preparation process |
| 06/16/2004 | CN1504196A Use of glycyrrhizin and its derivatives as mcp-1 production inhibitors |
| 06/16/2004 | CN1153780C Protein with thrombopoiesis substance activity |
| 06/16/2004 | CN1153771C Benzofuran-[3,4-f] quinoline derivatives, combination containing the same and application thereof |
| 06/16/2004 | CN1153770C Substitued nitrogen heterocyclic ring as inhibitors of P38 protein kinase |
| 06/16/2004 | CN1153766C Nitroketone compound, its preparing process and pharmaceutical composition containing same |
| 06/16/2004 | CN1153764C Substituted benzylaminopiperidine compounds |
| 06/16/2004 | CN1153759C Novel delta-amino-gamma-hydroxy-omega-aryl-alkane amide compounds |
| 06/16/2004 | CN1153590C Blood substitute of hemoglobin microcapsule and preparing method thereof |
| 06/16/2004 | CN1153568C Compounds active at a novel position on receptor-operated calcium channel useful for treatment of neurological disorders |
| 06/15/2004 | US6750349 Superior gastrokinetic properties |
| 06/15/2004 | US6750254 Nitric oxide-releasing amidine—and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same |
| 06/15/2004 | US6750243 COMPETITIVE INHIBITORS OF TRYPSIN-LIKE SERINE PROTEASES, ESPECIALLY THROMBIN; chemical synthesis; anticoagulants; treatment of thrombosis |
| 06/15/2004 | US6750242 Positive modulators of nicotinic receptor agonists |
| 06/15/2004 | US6750239 Useful for treating disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease |
| 06/15/2004 | US6750238 Aralkyl ester soft drugs |
| 06/15/2004 | US6750234 Regression of skin tumors, skin homeostases and remodeling, epidermal barrier development, hair growth, and especially wound healing. |
| 06/15/2004 | US6750232 2-aminopyridine compounds and use thereof as drugs |
| 06/15/2004 | US6750231 Skin disorders; gastrointestinal disorders |
| 06/15/2004 | US6750228 Uncontrolled breakdown of connective tissue by metalloproteases is a feature of many pathological conditions |
| 06/15/2004 | US6750226 For manufacture of medicament for use in therapy of respiratory, urinary or gastrointestinal disease |
| 06/15/2004 | US6750217 Anticancer agents; cardiovascular disorders; kinase inhibitor |
| 06/15/2004 | US6750208 Oligosaccharides are derived from carrageenans, agars or porphyrans |
| 06/15/2004 | US6750202 Inhibitors of procollagen c-proteinase (pcp), for treating fibrosis of the liver |
| 06/15/2004 | US6750044 For producing pharmaceutically active materials having therapeutic and pharmacologic properties that differ from native vegf protein |
| 06/15/2004 | US6750034 Useful as therapeutic agents for cancer, skin disorders, neuropathic pain, inflammatory, or coagulation diathesis/thrombosis; may also be useful for laundry detergents and skin care products; derived from humans |
| 06/15/2004 | US6749851 Applying radiation |
| 06/15/2004 | US6749840 Contacting the melanocyte with a melanin synthesis inhibiting amount of a fatty acid synthase (fas) inhibitor (such as cerulenin) to reduce melanin synthesis in the melanocyte |
| 06/15/2004 | CA2313302C New metalloprotease inhibitors, the process for preparing them and the pharmaceutical compounds containing them |
| 06/15/2004 | CA2192714C Quasiturbine (qurbine) zero vibration - continuous combustion rotary engine, compressor and pump |
| 06/15/2004 | CA2159330C Inhibition of leukocyte adhesion |
| 06/15/2004 | CA2153195C New benzopyran derivatives; process for preparing the same and pharmaceutical compositions containing them |
| 06/15/2004 | CA2086642C Method of treating hyperproliferative vascular disease |
| 06/10/2004 | WO2004048974A1 Functional domain and associated molecule of dock2 essentially required in lymphocyte migration |
| 06/10/2004 | WO2004048574A1 Immunoreceptor proteins |
| 06/10/2004 | WO2004048565A1 Apoptosis-associated protein and use thereof |
| 06/10/2004 | WO2004048498A1 Antioxidant, skin preparation for external use, cosmetic and food |
| 06/10/2004 | WO2004048379A1 Xanthine compound |
| 06/10/2004 | WO2004048371A1 Indolyl derivatives |
| 06/10/2004 | WO2004048366A1 2-oxoindoline derivatives |
| 06/10/2004 | WO2004048363A1 Imidazole derivative, process for producing the same, and use |
| 06/10/2004 | WO2004048360A1 Method of synthesizing macrosphelides |
| 06/10/2004 | WO2004048341A1 Novel heteroaryl derivative |
| 06/10/2004 | WO2004048339A1 Isoquinoline compounds and medicinal use thereof |
| 06/10/2004 | WO2004048331A1 N-arylalkyl-3-aminoalkoxyindoles and their use as 5-ht ligands |
| 06/10/2004 | WO2004047868A1 Remedy for glaucoma containing lim kinase inhibitory compound as active ingredient |
| 06/10/2004 | WO2004047851A1 Method of inhibiting cell death, cell death inhibitor and remedy for disease caused by cell death containing the cell death inhibitor |
| 06/10/2004 | WO2004047820A1 Warm poultice |
| 06/10/2004 | WO2004047725A2 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as hiv integrase inhibitors |
| 06/10/2004 | WO2004035093A3 Polymeric materials for site specific delivery to the body |
| 06/10/2004 | WO2004035030A3 Combinations of benzodithiazoles and cox-2 inhibitors for the treatment of pain |
| 06/10/2004 | WO2004024132A3 Use of no-signal cascade modulators and pharmaceutical composition |
| 06/10/2004 | WO2004022569A9 Akt inhibitors, pharmaceutical compositions, and uses thereof |
| 06/10/2004 | WO2004013285A3 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 06/10/2004 | WO2003102140A3 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis |
| 06/10/2004 | WO2003101950A3 Methods for enhancing motor performance and/or endurance |
| 06/10/2004 | WO2003083039A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 06/10/2004 | WO2003080037A3 Use of ltb4 antagonists in veterinary medicine |
| 06/10/2004 | WO2003072027A3 Compositions and formulations of 9- nitrocamptothecin polymorphs and methods of use thereof |
| 06/10/2004 | WO2003070970A3 RNA INTERFERENCE MEDIATED INHIBITION OF NF-KAPPA B/REL-A GENE EXPRESSION USING SHORT INTERFEREING NUCLEIC ACID (siNA) |
| 06/10/2004 | WO2003064626A3 Double-stranded oligonucleotides |
| 06/10/2004 | WO2003040170A9 Antibodies to cd40 |
| 06/10/2004 | WO2003035049A3 Use of potent, selective and non-toxic c-kit inhibitors for treating bacterial infections |
| 06/10/2004 | WO2003026689A8 Autologous growth factor cocktail composition, method of production and use |
| 06/10/2004 | WO2003013603A8 Modulators of p-selectin glycoprotein ligand 1 |
| 06/10/2004 | WO2002053091A3 Medicinal combination of a biguanine (metformin) and arginine |
| 06/10/2004 | WO2002040629A3 Promoters exhibiting endothelial cell specificity and methods of using same |
| 06/10/2004 | US20040110963 Novel hydrazones |
| 06/10/2004 | US20040110947 such as methyl-3-[([2-[(3-chloro-2,2-dimethylpropanoyl)amino]phenyl]thio)methyl]benzoate; lipid/lipoprotein metabolism |
| 06/10/2004 | US20040110935 Universal carrier for targeting molecules to Gb3 receptor expressing cells |
| 06/10/2004 | US20040110928 Peptide conjugates for drug delivery |
| 06/10/2004 | US20040110840 Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 06/10/2004 | US20040110832 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc |
| 06/10/2004 | US20040110831 Urokinase inhibitors |
| 06/10/2004 | US20040110826 Alpha 2c-adrenoceptor antagonists comprising 1- (benzylamino)-1,2,4]triazolo[1,5-c]pyrimidine derivatives; Parkinson's disease, dyskinesias, antidepressants; hypotensive, antidiabetic agents; eating,sexual disorders |
| 06/10/2004 | US20040110810 e.g., 2-(2-methyl-5-amino)phenyl-4-(3-pyridyl)-thiazole; c-kit inhibitors; treating cell proliferative, metabolic, allergic, and degenerative disorders. |
| 06/10/2004 | US20040110809 di- and tricycle-substituted imidazolidine-, oxazolidine- and thiazolidine diones and thiones, e.g., 5-[p-(quinolin-3-yl)-alpha-hydroxybenzyl]-5-methylimidazolidinedione |
| 06/10/2004 | US20040110805 Sulfur compounds such as 4-[(4-{3-[(2-adamantylamino)sulfonyl]propoxy}phenyl)sulfonyl]- N-hydroxytetrahydro-2H-pyran-4-carboximide, used as antagonists for metalloenzyme and/or aggrecanase activity; tissue repair |
| 06/10/2004 | US20040110801 Prevention of degenerative joint diseases, rheumatoid arthritis, osteoarthritis, ulcerative colitis, irritable colon and Crohn's diseas, antitumor agents; drug mixture for transdermal drug delivery, sustained release; chemical synthesis |
| 06/10/2004 | US20040110799 Use of a PPAR-alpha agonist to treat patients suffering from weight gain associated with a PPAR-gamma agonist treatment |
| 06/10/2004 | US20040110794 Novel piperidine derivatives as modulators of chemokine receptors |
| 06/10/2004 | US20040110793 Heterocyclo inhibitors of potassium channel function |
| 06/10/2004 | US20040110791 A 2-(naphthalene, quinoline, or benzothiophene-2-yl)-ethylamine derivatives, controlling of intraocular pressure, treating vision defects |
| 06/10/2004 | US20040110789 Substituted aminoquinuclidine compounds |
| 06/10/2004 | US20040110778 A 3,10-diaza-benzo[e]azulene, 3,8,10-triaza-benzo[e]azulene, or 1,3a,6-triaza-as-indacene derivatives, used to treat anxiety, depression, a sleep disorder, or Alzheimer's dementia. |
| 06/10/2004 | US20040110775 Cyclin dependent kinase inhibiting purine derivatives |
| 06/10/2004 | US20040110772 Inhibitors of nucleoside phosphorylases and nucleosidases |
| 06/10/2004 | US20040110770 Cyclin-dependent kinases (CDK); Cdc2/cyclin B (CDK-1) enzymatic complex; 1,3-dihydro-3-(imidazol-4-ylmethylene)-5-(pyrid-3-yl)-2H-indolin-2-one for example; antitumor agent |
| 06/10/2004 | US20040110769 Antitumor agents for cancer treatment; 5-(3-chlorophenyl)-alpha-(4-chlorophenyl)-alpha-(1-methyl-1H-imidazol-5-yl)tetrazolo[1,5-a]quinazoline-7-methanamine with tamoxifen for example |
| 06/10/2004 | US20040110768 (S)-3-(1H-indol-3-yl)-N-(1-methoxymethyl-cyclohexylmethyl)-2-methyl-2-[4-(4-nitro-phenyl)-oxazol-2-ylamino]-propionamide for example; cancer, psychological disorders, sexual disorders, eating disorders, inflammatory bowel disease, sleep disorders |
| 06/10/2004 | US20040110763 Pyrazolopyridine compound and pharmaceutical use thereof |
| 06/10/2004 | US20040110759 Inhibitors of IkB kinase (I Kappa B Kinase); treating various diseases including asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, cancer, infections, and cardiac infarct |
| 06/10/2004 | US20040110758 4,6-Diaminosubstituted-2-[oxy or aminoxy]-[1,3,5]triazines as protein tyrosine kinase inhibitors |
| 06/10/2004 | US20040110753 Tyrosine derivatives |